account_balanceBalance Sheet (BS) Summary

Updated: 03/31/20262026 Q1

Total Assets

107.8M USD

YoY -38.9%

Shareholders' Equity

95.5M USD

YoY -40.4%

Equity Ratio

88.6%

YoY -2.4pt

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

200150100500

2021

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2020

2021

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

-

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

-

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

-

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

-

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

-

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Acrivon Therapeutics, Inc. Common Stock

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data